[ET Net News Agency, 3 July 2025]  CSPC PHARMA (01093) rose 2.9% to HK$8.17.
  It hits an intra-day high of HK$8.19, and an intra-day low of HK$7.79. The total shares 
traded was 63.86 million, with a value of HK$510.7m. The active buy/sell ratio is 61:39,  
with net buying turnover of HK$105.66m. MACQUARIE CAPITAL accounts for greatest net 
responsive buying turnover of HK$17.61m, with volume weighted average price of HK$7.961.  
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of 
HK$30.77m, with volume weighted average price of HK$7.939. The stock has risen a combined 
6.1% over the past 2 consecutive trading days.
  The Hang Seng Index now fell 237 points, or 1% to 23,983; the Hang Seng China 
Enterprises Index now fell 99 points, or 1.1% to 8,625. 
  
          Basic Information 
          ================= 
  
  --------------------------------- 
  Nominal    8.170 % Chg    +2.90%
  High       8.190 Low       7.790
  Shares Tr 63.86m Turnover 510.7m
  10-D SMA   7.827 %H.V     63.486
  20-D SMA   8.234 VWAP      7.996
  50-D SMA   7.071 RSI14    58.101
  --------------------------------- 
Status: Active buy/sell ratio is 61:39, with net buying turnover of HK$105.66m, rising a  
combined 6.1% over the past 2 consecutive trading days
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)            Price (HK$) Change (%)
  ----------------------------------------------- 
  CSPC PHARMA (01093)            8.17      +2.90
  SINOPHARM (01099)             18.50  Unchanged
  SINO BIOPHARM (01177)          5.45      +2.25
  INNOVENT BIO (01801)          86.15      +8.64
  WUXI BIO (02269)              25.75      +0.39
  WUXI APPTEC (02359)           80.05      +1.01
  CHINARES PHARMA (03320)        5.20      -1.14
  HANSOH PHARMA (03692)         31.05      +3.10
  BEIGENE (06160)              150.30      +3.66
  AKESO (09926)                100.00      +7.76
  ----------------------------------------------- 
  (ed)



 
 